Switch to:

Top Direct Holders

HolderPositionShares% of Shares
Outstanding
Report Date
Dr. Randal W. Scott,PhDN/A1,185,1173.55%2012-07-10
Steven Shak,M.D.Chief Scientific Officer327,2070.98%2016-07-19
Joffre B. Baker,PhDN/A132,8460.4%2012-02-15
Dr. Fred E. Cohen,M.D.,D.Phil.N/A64,8930.19%2016-07-01
Kimberly J. PopovitsN/A58,7960.18%2016-02-15
G. Bradley ColeCOO35,4260.11%2016-08-11
Mr. James J. VaughnChief Commercial Officer29,079less than 0.1%2016-08-08
Mr. Frederic PlaN/A25,618less than 0.1%2016-02-15
Mr. Dean L. SchornoN/A24,524less than 0.1%2014-06-10
Brook H. ByersN/A23,951less than 0.1%2010-12-09

Insider Charts

Insider Transactions

Insider Position Date Buy/Sell Shares Shares Owned Following This (Direct & Indirect) Trade Price ($) Cost ($1000) Price Change
Since Trade (%)
Share Ownership Details
BAKER FELIXDirector, 10% Owner2016-08-15Buy100,00011,841,478$27.0227020
318,623 (See footnote(,))
11,348,958 (See footnote(,,))
173,897 (See footnote(F1,))
Cole G BradleyCOO2016-08-11Sell5,00035,426$28.87144.35-6.4135,426 (Direct)
Vaughn James JChief Commercial Officer2016-08-08Sell3,00029,079$28.7486.22-5.9829,079 (Direct)
Shak StevenChief Scientific Officer2016-07-19Sell5,000327,207$27.42137.1-1.46327,207 (Direct)
Cole G BradleyCOO2016-07-06Sell5,00035,426$26.64133.21.4335,426 (Direct)
Shak StevenChief Scientific Officer2016-06-21Sell5,000327,207$25.77128.854.85327,207 (Direct)
Cole G BradleyCOO2016-06-09Sell5,00035,426$26.62133.11.535,426 (Direct)
Vaughn James JChief Commercial Officer2016-06-06Sell1,99732,079$2855.92-3.532,079 (Direct)
Cole G BradleyCOO2016-05-16Sell5,00034,970$27.6138-2.134,970 (Direct)
Febbo Phillip G.Chief Medical Officer2016-05-10Sell6,32415,013$27.2172.01-0.6615,013 (Direct)
Vaughn James JChief Commercial Officer2016-05-09Sell2,00031,255$2856-3.531,255 (Direct)
Shak StevenChief Scientific Officer2016-05-04Sell10,000326,383$25.43254.36.25326,383 (Direct)
Vaughn James JChief Commercial Officer2016-02-09Sell324,076$280.08-3.524,076 (Direct)
LIVINGSTON RANDALL SDirector2016-01-13Sell1,2506,149$32.1440.18-15.936,149 (Direct)
Cole G BradleyCOO2016-01-12Sell4,00027,428$31.69126.76-14.7427,428 (Direct)
Vaughn James JChief Commercial Officer2016-01-07Sell2,00024,076$33.6367.26-19.6624,076 (Direct)
Cole G BradleyCOO2015-12-08Sell4,00027,428$29.26117.04-7.6627,428 (Direct)
Leber LauraChief Communication Officer2015-12-07Sell4,20012,959$29.33123.19-7.8812,959 (Direct)
Vaughn James JChief Commercial Officer2015-12-07Sell2,00024,076$29.3358.66-7.8824,076 (Direct)
Cole G BradleyCOO2015-11-10Sell4,00030,326$26.03104.123.830,326 (Direct)
Cole G BradleyCOO2015-09-09Sell9,66430,326$25.35244.986.5930,326 (Direct)
Cole G BradleyCOO2015-07-07Sell4,00030,326$27.53110.12-1.8530,326 (Direct)
Cole G BradleyCOO2015-06-09Sell4,00030,326$26.24104.962.9730,326 (Direct)
Cole G BradleyCOO2015-05-12Sell4,00029,658$27.54110.16-1.8929,658 (Direct)
Popovits Kimberly JPresident and CEO
(Click for the stocks that their CEOs have bought)
2015-04-13Sell3,000203,001$31.2893.84-13.62Link
Cole G BradleyCOO2015-04-07Sell4,00029,658$30.44121.76-11.2429,658 (Direct)
Popovits Kimberly JPresident and CEO2015-03-12Sell3,000204,101$31.9195.73-15.32Link
Cole G BradleyCOO2015-03-10Sell4,00029,658$31.84127.36-15.1429,658 (Direct)
Popovits Kimberly JPresident and CEO2015-02-12Sell3,000204,601$29.8689.58-9.51Link
Cole G BradleyCOO2015-02-10Sell4,00021,645$31.37125.48-13.8721,645 (Direct)
LIVINGSTON RANDALL SDirector2015-02-02Sell1,0006,149$31.9331.93-15.386,149 (Direct)
Popovits Kimberly JPresident and CEO2015-01-12Sell3,000204,601$33.46100.38-19.25Link
Popovits Kimberly JPresident and CEO2014-12-11Sell3,000204,601$32.9998.97-18.1Link
Cole G BradleyCOO2014-12-08Sell4,33621,645$32.52141.01-16.9121,645 (Direct)
Popovits Kimberly JPresident and CEO2014-11-12Sell4,300205,201$34.82149.73-22.4Link
Cole G BradleyCOO2014-11-10Sell4,00022,891$35.35141.4-23.5622,891 (Direct)
LIVINGSTON RANDALL SDirector2014-11-03Sell3,0006,149$36.24108.72-25.446,149 (Direct)
Popovits Kimberly JPresident and CEO2014-10-13Sell3,000205,201$30.7892.34-12.22Link
Cole G BradleyCOO2014-10-08Sell4,00022,891$28.77115.08-6.0822,891 (Direct)
Popovits Kimberly JPresident and CEO2014-09-11Sell3,000205,201$29.8289.46-9.39Link
Cole G BradleyCOO2014-09-08Sell4,70022,891$30.09141.42-10.222,891 (Direct)
Shak StevenEVP of R&D2014-08-14Sell13,348312,298$27.36365.2-1.24312,298 (Direct)
Popovits Kimberly JPresident and CEO2014-08-12Sell3,000205,201$26.0778.213.64Link
Popovits Kimberly JPresident and CEO2014-07-14Sell3,000205,201$26.5979.771.62Link
Cole G BradleyCOO2014-07-08Sell2,30022,891$27.0562.22-0.1122,891 (Direct)
Shak StevenEVP of R&D2014-07-01Sell7,000312,298$271890.07312,298 (Direct)
Shak StevenEVP of R&D2014-06-12Sell7,000312,298$26.73187.111.08312,298 (Direct)
Popovits Kimberly JPresident and CEO2014-06-12Sell3,000271,289$26.178.33.52Link
Schorno Dean LCFO2014-06-10Sell4,00030,673$27.62110.48-2.1724,524 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2014-06-09Sell2,33722,891$27.2963.78-0.9922,891 (Direct)
Popovits Kimberly JPresident and CEO2014-05-12Sell3,000270,579$26.5479.621.81Link
Schorno Dean LCFO2014-05-09Sell4,00029,963$25.09100.367.6923,814 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Shak StevenEVP of R&D2014-04-14Sell7,000311,588$26.25183.752.93311,588 (Direct)
Cole G BradleyCOO2014-04-08Sell3,00022,226$27810.0722,226 (Direct)
Shak StevenEVP of R&D2014-03-14Sell7,000311,588$28.36198.52-4.72311,588 (Direct)
Cole G BradleyCOO2014-03-10Sell3,00022,226$27.7683.28-2.6722,226 (Direct)
HIBBS KATHY LSVP & General Counsel2014-02-18Sell1,31215,787$27.8836.58-3.0815,787 (Direct)
Shak StevenEVP of R&D2014-02-14Sell7,000311,588$27.38191.66-1.31311,588 (Direct)
Cole G BradleyCOO2014-02-10Sell3,00024,789$27810.0724,789 (Direct)
Shak StevenEVP of R&D2014-01-15Sell7,000308,283$31.51220.57-14.25308,283 (Direct)
Popovits Kimberly JPresident and CEO2014-01-13Sell2,500261,190$3075-9.93Link
Cole G BradleyCOO2014-01-08Sell3,00018,369$28.1784.51-4.0818,369 (Direct)
Shak StevenEVP of R&D & CMO2013-12-17Sell14,000308,283$29.57413.98-8.62308,283 (Direct)
Popovits Kimberly JPresident and CEO2013-12-12Sell2,5000$30.6876.7-11.93Link
Schorno Dean LCFO2013-12-09Sell3,00027,706$33.2599.75-18.7421,557 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
LIVINGSTON RANDALL SDirector2013-12-02Sell1,0006,149$34.9234.92-22.626,149 (Direct)
Popovits Kimberly JPresident and CEO2013-11-13Sell5,0000$34.58172.9-21.86Link
Schorno Dean LCFO2013-11-08Sell3,00027,585$33.36100.08-1921,436 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2013-11-06Sell2,86818,135$31.3890-13.8918,135 (Direct)
Shak StevenEVP of R&D & CMO2013-10-15Sell5,000308,283$29.67148.35-8.93308,283 (Direct)
Popovits Kimberly JPresident and CEO2013-10-10Sell2,5000$3075-9.93Link
Cole G BradleyCOO2013-10-09Sell2,50018,135$29.9574.88-9.7818,135 (Direct)
Shak StevenEVP of R&D & CMO2013-09-18Sell5,000313,283$33.73168.65-19.89313,283 (Direct)
Popovits Kimberly JPresident and CEO2013-09-12Sell2,5000$34.3185.78-21.25Link
Cole G BradleyCOO2013-09-09Sell2,50018,135$32.5381.33-16.9418,135 (Direct)
Schorno Dean LCFO2013-09-06Sell4,00027,585$32.9131.6-17.8721,436 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
LIVINGSTON RANDALL SDirector2013-09-03Sell1,0006,149$31.4931.49-14.196,149 (Direct)
Shak StevenEVP of R&D & CMO2013-08-14Sell5,000318,283$32.98164.9-18.07318,283 (Direct)
Popovits Kimberly JPresident and CEO2013-08-12Sell2,5000$33.0382.58-18.2Link
Schorno Dean LCFO2013-08-09Sell4,00027,585$33.15132.6-18.4921,436 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Schorno Dean LCFO2013-08-09Sell4,00027,585$33.15132.6-18.4921,436 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2013-08-07Sell2,50019,135$33.6684.15-19.7319,135 (Direct)
Shak StevenEVP of R&D & CMO2013-07-23Sell5,000318,283$35.33176.65-23.52318,283 (Direct)
Popovits Kimberly JPresident and CEO2013-07-12Sell5,0000$34.61173.05-21.93Link
Schorno Dean LCFO2013-07-09Sell4,00023,985$33.81135.24-20.0817,836 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Schorno Dean LCFO2013-07-09Sell4,00023,985$33.81135.24-20.0817,836 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2013-07-08Sell2,50013,135$33.3383.33-18.9313,135 (Direct)
Shak StevenEVP of R&D & CMO2013-06-18Sell5,000323,283$33.52167.6-19.39323,283 (Direct)
Popovits Kimberly JPresident and CEO2013-06-12Sell5,0000$35.68178.4-24.27Link
Schorno Dean LCFO2013-06-10Sell4,00023,985$35.88143.52-24.6917,836 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
BAKER FELIXDirector, 10% Owner2013-06-05Buy381,43213,288,253$36.1613792.58-25.28
1,730,777 (See Footnote)
11,241,654 (See Footnotes(F7,F14,F15))
301,215 (See Footnotes(F9,F14,F15))
14,607 (See Footnote(F9,F14,F15))
Cole G BradleyCOO2013-06-05Sell2,50013,135$36.4791.18-25.9113,135 (Direct)
BAKER FELIXDirector, 10% Owner2013-06-03Buy179,58312,906,821$36.716592.49-26.4
1,690,226 (See Footnote)
10,909,066 (See Footnotes(F7,F14,F15))
292,922 (See Footnotes(F9,F14,F15))
14,607 (See Footnote(F9,F14,F15))
LIVINGSTON RANDALL SDirector2013-06-03Sell1,0006,149$36.436.4-25.776,149 (Direct)
BAKER FELIXDirector, 10% Owner2013-05-29Buy121,26612,727,238$36.894473.5-26.76
1,671,081 (See Footnote)
10,752,532 (See Footnotes(F7,F14,F15))
289,018 (See Footnotes(F9,F14,F15))
14,607 (See Footnote(F9,F14,F15))
BAKER FELIXDirector, 10% Owner2013-05-24Buy79,41714,257,273$36.932932.87-26.83
1,651,301 (See Footnote)
10,646,920 (See Footnotes(F7,F17,F18))
286,384 (See Footnotes(F9,F17,F18))
1,658,061 (See Footnotes(F5,F17,F18))
14,607 (See Footnote(F9,F17,F18))
HIBBS KATHY LSVP & General Counsel2013-05-22Sell1,0007,087$37.4837.48-27.917,087 (Direct)
Shak StevenEVP of R&D & CMO2013-05-21Sell5,000327,380$37.19185.95-27.35327,380 (Direct)
BAKER FELIXDirector, 10% Owner2013-05-16Buy71,43912,526,555$36.452603.95-25.87
1,649,473 (See Footnote)
10,577,816 (See Footnotes(F7,F14,F15))
284,659 (See Footnotes(F9,F14,F15))
14,607 (See Footnote(F9,F14,F15))
LIVINGSTON RANDALL SDirector2013-05-15Sell1,3376,149$35.8347.9-24.596,149 (Direct)
BAKER FELIXDirector, 10% Owner2013-05-14Buy240,42614,093,759$34.348256.23-21.32
1,638,643 (See Footnote)
10,515,769 (See Footnotes(F7,F17,F18))
283,112 (See Footnotes(F9,F17,F18))
1,641,628 (See Footnotes(F5,F17,F18))
14,607 (See Footnote(F9,F17,F18))
HIBBS KATHY LSVP & General Counsel2013-05-13Sell1,2507,087$34.4243.03-21.57,087 (Direct)
Popovits Kimberly JPresident and CEO2013-05-13Sell5,0000$34.7173.5-22.13Link
Schorno Dean LCFO2013-05-09Sell4,00023,241$36.02144.08-24.9917,092 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2013-05-08Sell2,50012,540$35.9989.98-24.9212,540 (Direct)
Popovits Kimberly JPresident and CEO2013-04-23Sell2,5000$3075-9.93Link
Cole G BradleyCOO2013-04-03Sell2,50012,540$27.7969.48-2.7712,540 (Direct)
Cole G BradleyCOO2013-03-06Sell2,50012,540$28.5771.43-5.4312,540 (Direct)
BAKER FELIXDirector, 10% Owner2013-02-21Buy49,08512,211,834$27.781363.58-2.74
1,614,513 (See Footnote)
10,306,239 (See Footnotes(F7,F14,F15))
277,189 (See Footnotes(F9,F14,F15))
13,893 (See Footnote(F9,F14,F15))
HIBBS KATHY LSVP & General Counsel2013-02-20Sell2,7167,087$28.1376.4-3.957,087 (Direct)
BAKER FELIXDirector, 10% Owner2013-02-14Buy52,00012,162,749$28.481480.96-5.13
1,609,152 (See Footnote)
10,263,580 (See Footnotes(F7,F14,F15))
276,124 (See Footnotes(F9,F14,F15))
13,893 (See Footnote(F9,F14,F15))
MYERS WOODROW A JRDirector2013-02-14Sell41,2502,891$28.41171.5-4.862,891 (Direct)
BAKER FELIXDirector, 10% Owner2013-02-11Buy116,36012,110,749$28.153275.53-4.01
1,603,265 (See Footnote)
10,218,600 (See Footnotes(F7,F14,F15))
274,991 (See Footnotes(F9,F14,F15))
13,893 (See Footnote(F9,F14,F15))
Cole G BradleyCOO2013-02-06Sell2,50014,085$28.0370.08-3.614,085 (Direct)
LIVINGSTON RANDALL SDirector2013-01-28Sell2,0006,149$28.7757.54-6.086,149 (Direct)
Schorno Dean LCFO2013-01-09Sell2,62523,504$2873.5-3.517,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2013-01-09Sell2,50014,085$27.8869.7-3.0814,085 (Direct)
Shak StevenEVP of R&D & CMO2012-12-18Sell5,000333,768$27.74138.7-2.6333,768 (Direct)
Popovits Kimberly JPresident and CEO2012-12-13Sell5,0000$27.79138.95-2.77Link
Schorno Dean LCFO2012-12-11Sell3,00023,504$2884-3.517,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
LIVINGSTON RANDALL SDirector2012-11-26Sell2,0006,149$27.8455.68-2.956,149 (Direct)
BAKER FELIXDirector, 10% Owner2012-11-21Buy229,30012,263,857$26.836152.120.71288 (Direct)
271,800 (See Footnote)
1,589,551 (See Footnotes(F5,F14,F15))
10,117,174 (See Footnotes(F7,F14,F15))
271,806 (See Footnotes(F9,F14,F15))
13,238 (See Footnote(F9,F14,F15))
COLELLA SAMUEL DDirector2012-11-20Sell30,61636,437$26.89823.260.4836,437 (Direct)
0 (Versant Venture Capital I, L.P.)
0 (Versant Side Fund I, L.P.)
0 (Versant Affiliates Fund I-A, L.P.)
0 (Versant Affiliates Fund I-B, L.P.)
Shak StevenEVP of R&D & CMO2012-11-20Sell5,000338,768$26.94134.70.3338,768 (Direct)
BAKER FELIXDirector, 10% Owner2012-11-14Buy103,16713,526$27.322818.52-1.1288 (Direct)
13,238 (See Footnote)
Popovits Kimberly JPresident and CEO2012-11-14Sell5,0000$27.24136.2-0.81Link
BAKER FELIXDirector, 10% Owner2012-11-13Buy823,77213,526$27.8122909.1-2.84288 (Direct)
13,238 (See Footnote)
Schorno Dean LCFO2012-11-12Sell3,00023,504$2884-3.517,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2012-11-08Sell2,50014,085$28.6271.55-5.5914,085 (Direct)
Popovits Kimberly JPresident and CEO2012-10-16Sell10,0000$33.08330.8-18.32Link
Shak StevenEVP of R&D & CMO2012-10-16Sell5,000343,768$35.25176.25-23.35343,768 (Direct)
Schorno Dean LCFO2012-10-12Sell3,00023,504$33.79101.37-20.0417,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
HIBBS KATHY LSVP & General Counsel2012-10-11Sell1,25011,367$33.7842.23-20.0111,367 (Direct)
Cole G BradleyCOO2012-10-09Sell2,50014,085$34.887-22.3614,085 (Direct)
Shak StevenEVP of R&D & CMO2012-09-18Sell5,000348,768$33.76168.8-19.96348,768 (Direct)
Popovits Kimberly JPresident and CEO2012-09-13Sell5,0000$31.69158.45-14.74Link
Cole G BradleyCOO2012-09-06Sell2,50014,085$35.0187.53-22.8214,085 (Direct)
MYERS WOODROW A JRDirector2012-08-21Sell16,5002,236$35.2580.8-23.242,236 (Direct)
Shak StevenEVP of R&D & CMO2012-08-20Sell5,000353,768$34.99174.95-22.78353,768 (Direct)
Popovits Kimberly JPresident and CEO2012-08-13Sell10,0000$34.72347.2-22.18Link
Cole G BradleyCOO2012-08-08Sell2,50014,085$30.4976.23-11.3814,085 (Direct)
LIVINGSTON RANDALL SDirector2012-07-26Sell2,0006,149$35.971.8-24.746,149 (Direct)
Shak StevenChief Medical Officer2012-07-24Sell5,000358,768$34.24171.2-21.09358,768 (Direct)
Popovits Kimberly JPresident and CEO2012-07-13Sell7,1000$34.76246.8-22.27Link
Scott Randal WCEO, InVitae Corporation*2012-07-11Sell30,0000$35.391061.7-23.65Link
Cole G BradleyCOO2012-07-05Sell2,50014,085$35.9589.88-24.8414,085 (Direct)
Shak StevenChief Medical Officer2012-06-25Sell5,000363,768$33.25166.25-18.74363,768 (Direct)
Popovits Kimberly JPresident and CEO2012-06-13Sell5,0000$33.36166.8-19Link
Popovits Kimberly JPresident and CEO2012-06-13Sell5,0000$33.36166.8-19Link
Scott Randal WCEO, InVitae Corporation*2012-06-12Sell30,0000$33.541006.2-19.44Link
Cole G BradleyCOO2012-06-06Sell2,50013,507$33.9784.93-20.4613,507 (Direct)
Shak StevenChief Medical Officer2012-05-24Sell5,000367,849$33.8169-20.06367,849 (Direct)
BAKER JULIANDirector, 10% Owner2012-05-22Buy167,4061,488,539$32.265400.52-16.24
1,488,539 (See Footnote)
COLELLA SAMUEL DDirector2012-05-18Sell26,294664,113$33.03868.49-18.226,891 (Direct)
582,174 (Versant Venture Capital I, L.P.)
11,210 (Versant Side Fund I, L.P.)
13,222 (Colella Family Partners, L.P.)
10,414 (Versant Affiliates Fund I-A, L.P.)
20,202 (Versant Affiliates Fund I-B, L.P.)
BAKER JULIANDirector, 10% Owner2012-05-16Buy376,0591,488,539$33.8812740.88-20.25
1,488,539 (See Footnote)
Popovits Kimberly JPresident and CEO2012-05-16Sell10,0000$34.23342.3-21.06Link
Schorno Dean LCFO2012-05-15Sell1,00023,504$33.6933.69-19.817,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
BAKER JULIANDirector, 10% Owner2012-05-11Buy114,8881,488,539$29.963442.04-9.81
1,488,539 (See Footnote)
Scott Randal WCEO, InVitae Corporation*2012-05-11Sell30,0000$30.22906.6-10.59Link
Cole G BradleyCOO2012-05-09Sell2,50013,507$28.8772.18-6.4113,507 (Direct)
BAKER JULIANDirector, 10% Owner2012-05-08Buy195,70113,238$28.455567.69-5.03
13,238 (See Footnote)
LIVINGSTON RANDALL SDirector2012-04-26Sell2,0006,149$28.2156.42-4.226,149 (Direct)
Shak StevenChief Medical Officer2012-04-24Sell5,000372,849$27.93139.65-3.26372,849 (Direct)
Popovits Kimberly JPresident and CEO2012-04-23Sell5,0000$27.79138.95-2.77Link
Schorno Dean LCFO2012-04-16Sell1,00024,504$27.9827.98-3.4318,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Scott Randal WCEO, InVitae Corporation*2012-04-11Sell20,0000$28.59571.8-5.49Link
Cole G BradleyCOO2012-04-04Sell2,50013,507$30.2875.7-10.7713,507 (Direct)
Shak StevenChief Medical Officer2012-03-22Sell5,000377,849$30.08150.4-10.17377,849 (Direct)
Popovits Kimberly JPresident and CEO2012-03-22Sell5,0000$30.07150.35-10.14Link
Popovits Kimberly JPresident and CEO2012-03-22Sell5,0000$30.07150.35-10.14Link
Shak StevenChief Medical Officer2012-03-22Sell5,000377,849$30.08150.4-10.17377,849 (Direct)
Schorno Dean LCFO2012-03-15Sell1,00025,504$31.0831.08-13.0619,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Scott Randal WCEO, InVitae Corporation2012-03-13Sell30,0000$31.05931.5-12.98Link
Cole G BradleyCOO2012-03-08Sell2,50013,507$29.9474.85-9.7513,507 (Direct)
Baker Biotech Capital (GP), LLDirector, 10% Owner2012-03-08Buy4,5081,484,977$30.11135.74-10.26
1,484,977 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2012-03-08Buy1,099227,840$30.1133.09-10.26
227,840 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2012-03-08Buy41,5848,255,421$30.111252.09-10.26
8,255,421 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2012-03-05Buy261,7618,213,837$29.817803.1-9.36
8,213,837 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2012-03-05Buy6,923226,741$29.81206.37-9.36
226,741 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2012-03-05Buy31,3321,480,469$29.81934.01-9.36
1,480,469 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2012-02-29Buy6,476219,818$29.06188.19-7.02
219,818 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2012-02-29Buy245,0317,952,076$29.067120.6-7.02
7,952,076 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2012-02-29Buy29,7561,449,137$29.06864.71-7.02
1,449,137 (Through Partnership)
Popovits Kimberly JPresident and CEO2012-02-24Sell10,0000$28.5285-5.19Link
Baker Brothers Life Sciences CDirector, 10% Owner2012-02-23Buy114,5187,707,045$28.063213.38-3.71
7,707,045 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2012-02-23Buy3,022213,342$28.0684.8-3.71
213,342 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2012-02-23Buy13,3321,419,381$28.06374.1-3.71
1,419,381 (Through Partnership)
Shak StevenChief Medical Officer2012-02-23Sell5,000382,849$28.14140.7-3.98382,849 (Direct)
Baker Biotech Capital (GP), LLDirector, 10% Owner2012-02-16Buy33,1851,406,049$29.34973.65-7.91
1,406,049 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2012-02-16Buy7,213210,320$29.37211.85-8
210,320 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2012-02-16Buy272,9097,592,527$29.378015.34-8
7,592,527 (Through Partnership)
Schorno Dean LCFO2012-02-15Sell75526,749$28.7621.71-6.0520,600 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Schorno Dean LCFO2012-02-15Sell1,00026,504$28.7628.76-6.0520,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Baker Brothers Life Sciences CDirector, 10% Owner2012-02-10Buy417,9157,319,618$26.3611016.242.5
7,319,618 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2012-02-10Buy11,043203,107$26.36291.092.5
203,107 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2012-02-10Buy66,5831,372,864$26.361755.132.5
1,372,864 (Through Partnership)
Scott Randal WExecutive Chairman2012-02-10Sell20,0000$26.18523.63.21Link
Scott Randal WExecutive Chairman2012-02-10Sell20,0000$26.18523.63.21Link
Cole G BradleyCOO2012-02-08Sell2,50014,450$26.4766.182.0814,450 (Direct)
LIVINGSTON RANDALL SDirector2012-01-26Sell2,0006,149$27.5155.02-1.786,149 (Direct)
Popovits Kimberly JPresident and CEO2012-01-25Sell5,0000$26.42132.12.27Link
Popovits Kimberly JPresident and CEO2012-01-24Sell5,0000$26.62133.11.5Link
Shak StevenChief Medical Officer2012-01-24Sell5,000382,778$26.74133.71.05382,778 (Direct)
Schorno Dean LCFO2012-01-17Sell1,00024,049$2828-3.517,900 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2012-01-12Sell2,5007,750$27.5468.85-1.897,750 (Direct)
Scott Randal WExecutive Chairman2012-01-11Sell20,0000$27.46549.2-1.6Link
Shak StevenChief Medical Officer2011-12-22Sell5,000387,778$26.03130.153.8387,778 (Direct)
Scott Randal WExecutive Chairman2011-12-13Sell20,0000$27.29545.8-0.99Link
Cole G BradleyCOO2011-12-06Sell2,5007,750$28.5971.48-5.497,750 (Direct)
14159 capital (GP), LLCDirector, 10% Owner2011-12-05Buy3,152192,064$28.1288.63-3.91
192,064 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2011-12-05Buy45,9771,306,281$27.661271.72-2.31
1,306,281 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2011-12-05Buy117,7516,901,703$28.123311.16-3.91
6,901,703 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2011-11-23Buy5,5311,260,304$25.91143.314.28
1,260,304 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2011-11-23Buy5,750188,912$25.94149.164.16
188,912 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2011-11-23Buy193,7396,783,952$25.915019.784.28
6,783,952 (Through Partnership)
Shak StevenChief Medical Officer2011-11-22Sell5,000392,778$26.07130.353.64392,778 (Direct)
Baker Brothers Life Sciences CDirector, 10% Owner2011-11-16Buy64,5976,590,213$27.711789.98-2.49
6,590,213 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2011-11-16Buy2,550183,162$27.7170.66-2.49
183,162 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2011-11-16Buy4581,254,773$27.3512.53-1.21
1,254,773 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2011-11-14Buy10,106180,612$27.23275.19-0.77
180,612 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2011-11-14Buy249,3756,525,616$27.236790.48-0.77
6,525,616 (Through Partnership)
Scott Randal WExecutive Chairman2011-11-11Sell20,0000$27.24544.8-0.81Link
Baker Biotech Capital (GP), LLDirector, 10% Owner2011-11-09Buy5421,254,315$26.7914.520.86
1,254,315 (Through Partnership)
Cole G BradleyCOO2011-11-08Sell2,5007,750$26.666.51.587,750 (Direct)
Baker Brothers Life Sciences CDirector, 10% Owner2011-11-07Buy209,5126,276,241$25.945434.744.16
6,276,241 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2011-11-07Buy8,847170,506$25.94229.494.16
170,506 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2011-11-03Buy1201,253,773$24.482.9410.38
1,253,773 (Through Partnership)
LIVINGSTON RANDALL SDirector2011-10-27Sell2,0006,149$22.0844.1622.376,149 (Direct)
Shak StevenChief Medical Officer2011-10-24Sell5,000392,778$21.76108.824.17392,778 (Direct)
Scott Randal WExecutive Chairman2011-10-11Sell20,0000$22.83456.618.35Link
Cole G BradleyCOO2011-10-06Sell5,0007,750$22.31111.5521.117,750 (Direct)
Scott Randal WExecutive Chairman2011-09-13Sell20,0000$20.81416.229.84Link
Cole G BradleyCOO2011-09-06Sell2,5007,750$22.0855.222.377,750 (Direct)
Shak StevenChief Medical Officer2011-08-24Sell5,000392,778$23.02115.117.38392,778 (Direct)
Scott Randal WExecutive Chairman2011-08-11Sell20,0000$24.44488.810.56Link
Cole G BradleyCOO2011-08-08Sell2,5007,750$25.2663.156.977,750 (Direct)
Cole G BradleyCOO2011-08-08Sell2,5007,750$25.2663.156.977,750 (Direct)
LIVINGSTON RANDALL SDirector2011-07-27Sell2,0006,149$26.4552.92.166,149 (Direct)
Shak StevenChief Medical Officer2011-07-25Sell5,000392,778$27.61138.05-2.14392,778 (Direct)
Scott Randal WExecutive Chairman2011-07-12Sell20,0001,503,444$27.36547.2-1.241,491,146 (Direct)
12,298 (By Morgan Stanley DW Inc. as Custodian for Randal W. Scott, IRA)
Cole G BradleyCOO2011-07-06Sell5,0007,750$27.74138.7-2.67,750 (Direct)
Shak StevenChief Medical Officer2011-06-23Sell5,000392,778$27.12135.6-0.37392,778 (Direct)
Schorno Dean LCFO2011-06-15Sell1,00025,049$25.9125.914.2818,900 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Scott Randal WExecutive Chairman2011-06-13Sell20,0001,523,444$25.69513.85.181,511,146 (Direct)
12,298 (By Morgan Stanley DW Inc. as Custodian for Randal W. Scott, IRA)
Baker Bros. Capital (GP), LLCDirector, 10% Owner2011-06-09Buy119194,415$26.193.123.17
194,415 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2011-06-09Buy4,388161,659$26.19114.923.17
161,659 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2011-06-09Buy203,6526,059,449$26.25335.683.13
6,059,449 (Through Partnership)
Cole G BradleyCOO2011-06-06Sell2,5007,750$26.1865.453.217,750 (Direct)
14159 capital (GP), LLCDirector, 10% Owner2011-06-01Buy4,631157,271$27.34126.61-1.17
157,271 (Through Partnership)
Baker Bros. Capital (GP), LLCDirector, 10% Owner2011-06-01Buy112194,296$27.353.06-1.21
194,296 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2011-06-01Buy181,6935,855,797$27.354969.3-1.21
5,855,797 (Through Partnership)
Shak StevenChief Medical Officer2011-05-25Sell5,000392,778$25.55127.755.75392,778 (Direct)
Schorno Dean LCFO2011-05-12Sell1,00026,049$26.4826.482.0419,900 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Scott Randal WExecutive Chairman2011-05-11Sell20,0000$26.66533.21.35Link
Cole G BradleyCOO2011-05-09Sell2,5007,750$25.9364.834.27,750 (Direct)
LIVINGSTON RANDALL SDirector2011-04-27Sell2,0000$26.0452.083.76Link
Shak StevenChief Medical Officer2011-04-25Sell5,0000$25.38126.96.46Link
Popovits Kimberly JPresident and CEO2011-04-15Sell8,0000$25.49203.926Link
Schorno Dean LCFO2011-04-14Sell1,0000$25.3225.326.71Link
Scott Randal WExecutive Chairman2011-04-12Sell20,0000$25.96519.24.08Link
Cole G BradleyCOO2011-04-06Sell5,0000$26.91134.550.41Link
Shak StevenChief Medical Officer2011-03-24Sell5,0000$24.45122.2510.51Link
Schorno Dean LCFO2011-03-15Sell1,0000$23.7923.7913.58Link
Popovits Kimberly JPresident and CEO2011-03-15Sell8,0000$24.29194.3211.24Link
Popovits Kimberly JPresident and CEO2011-03-15Sell8,0000$24.29194.3211.24Link
Scott Randal WExecutive Chairman2011-03-11Sell20,0000$25.62512.45.46Link
Baker Brothers Life Sciences CDirector, 10% Owner2011-03-10Buy70,8560$26.031844.383.8Link
14159 capital (GP), LLCDirector, 10% Owner2011-03-08Buy9,6480$25.06241.787.82Link
Baker Brothers Life Sciences CDirector, 10% Owner2011-03-08Buy349,5660$25.068760.127.82Link
Cole G BradleyCOO2011-03-08Sell2,5000$25.2363.087.09Link
COLELLA SAMUEL DDirector2011-03-03Sell34,3200$25.45873.446.17Link
Baker Brothers Life Sciences CDirector, 10% Owner2011-03-02Buy160,3370$25.694119.065.18Link
14159 capital (GP), LLCDirector, 10% Owner2011-03-02Buy4,4260$25.69113.75.18Link
Baker Brothers Life Sciences CDirector, 10% Owner2011-02-25Buy158,3550$23.393703.9215.52Link
14159 capital (GP), LLCDirector, 10% Owner2011-02-25Buy4,3700$23.39102.2115.52Link
Shak StevenChief Medical Officer2011-02-24Sell5,0000$23.27116.3516.12Link
Schorno Dean LCFO2011-02-15Sell1,0000$22.5122.5120.04Link
Popovits Kimberly JPresident and CEO2011-02-15Sell8,0000$22.51180.0820.04Link
Scott Randal WExecutive Chairman2011-02-11Sell20,0000$22.244421.71Link
Popovits Kimberly JPresident and CEO2011-01-18Sell8,000309,424$21.15169.227.75Link
Popovits Kimberly JPresident and CEO2011-01-18Sell8,0000$21.15169.227.75Link
Schorno Dean LCFO2011-01-13Sell1,27626,149$21.0626.8728.3Link
Scott Randal WExecutive Chairman2011-01-11Sell20,0001,642,410$21.73434.624.34Link
Cole G BradleyCOO2011-01-06Sell5,0001,000$22.13110.6522.1Link
Popovits Kimberly JPresident and CEO2010-12-16Sell8,000310,624$22.71181.6818.98Link
Scott Randal WExecutive Chairman2010-12-13Sell20,0001,696,410$22.46449.220.3Link
Cole G BradleyCOO & CFO2010-12-13Sell2,5001,000$22.6456.619.35Link
Popovits Kimberly JPresident and CEO2010-11-16Sell8,000310,624$17.514054.4Link
Cole G BradleyCOO & CFO2010-11-11Sell2,5001,000$18.0445.149.78Link
Scott Randal WExecutive Chairman2010-11-11Sell20,0001,666,410$18.27365.447.89Link
Scott Randal WExecutive Chairman2010-10-12Sell20,0001,686,410$13.9527993.69Link
Popovits Kimberly JPresident and CEO2010-09-15Sell7,734310,624$15.1116.7878.94Link
Scott Randal WExecutive Chairman2010-09-13Sell20,0001,706,410$14.87297.481.71Link
Cole G BradleyCOO & CFO2010-09-13Sell2,5001,000$15.0137.5380.01Link
14159 capital (GP), LLCDirector, 10% Owner2010-09-09Buy145134,196$14.812.1582.44Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-09-09Buy5,2614,934,990$14.8177.9282.44Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-09-02Buy65,4664,929,729$14.46946.6486.86Link
14159 capital (GP), LLCDirector, 10% Owner2010-09-02Buy1,807134,051$14.4626.1386.86Link
14159 capital (GP), LLCDirector, 10% Owner2010-08-30Buy3,415132,244$14.3749.0788.03Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-08-30Buy123,7114,864,263$14.371777.7388.03Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-08-23Buy150,4694,740,552$14.522184.8186.09Link
14159 capital (GP), LLCDirector, 10% Owner2010-08-23Buy4,153128,829$14.5260.386.09Link
14159 capital (GP), LLCDirector, 10% Owner2010-08-18Buy530124,676$14.997.9480.25Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-08-18Buy19,1874,590,083$14.99287.6180.25Link
Popovits Kimberly JPresident and CEO2010-08-17Sell8,000288,116$15.07120.5679.3Link
14159 capital (GP), LLCDirector, 10% Owner2010-08-13Buy2,924124,146$14.8543.4281.95Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-08-13Buy105,9104,570,896$14.851572.7681.95Link
Cole G BradleyCOO & CFO2010-08-12Sell2,5001,000$1537.580.13Link
Scott Randal WExecutive Chairman2010-08-11Sell20,0001,726,410$14.71294.283.68Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-08-10Buy164,2424,464,986$14.612399.5884.94Link
14159 capital (GP), LLCDirector, 10% Owner2010-08-10Buy4,533121,222$14.6166.2384.94Link
Baker JoffreChief Scientific Officer2010-08-09Sell4,629163,088$14.7568.2883.19Link
Scott Randal WExecutive Chairman2010-07-13Sell20,0001,746,410$12.81256.2110.93Link
Baker JoffreChief Scientific Officer2010-07-07Sell4,629167,717$13.0560.41107.05Link
Scott Randal WExecutive Chairman2010-06-11Sell20,0001,766,410$14.1528390.95Link
Baker JoffreChief Scientific Officer2010-06-10Sell4,629172,346$14.0565.0492.31Link
Popovits Kimberly JPresident and CEO2010-05-17Sell8,000310,624$15.78126.2471.23Link
Cole G BradleyCOO & CFO2010-05-12Sell2,5001,000$15.8739.6870.26Link
Scott Randal WExecutive Chairman2010-05-11Sell20,0001,776,410$15.61312.273.09Link
Baker JoffreChief Scientific Officer2010-05-10Sell4,629176,975$15.5171.874.21Link
Scott Randal WExecutive Chairman2010-04-13Sell20,0001,796,410$16.87337.460.17Link
Cole G BradleyCOO & CFO2010-04-12Sell5,0001,000$16.984.559.88Link
Baker JoffreChief Scientific Officer2010-04-12Sell4,629181,604$16.8878.1460.07Link
Popovits Kimberly JPresident and CEO2010-03-16Sell20,000288,116$19.4538938.92Link
Scott Randal WExecutive Chairman2010-03-11Sell20,0001,800,646$19.338640Link
Cole G BradleyCOO & CFO2010-03-11Sell2,5001,000$19.3948.4839.35Link
COLELLA SAMUEL DDirector2010-03-10Sell106,70085,050$19.452075.3238.92Link
Baker JoffreChief Scientific Officer2010-03-08Sell4,629150,120$19.8391.7936.26Link
14159 capital (GP), LLCDirector, 10% Owner2010-02-19Buy3,645116,689$17.0562.1558.48Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-02-19Buy132,0704,300,744$17.052251.7958.48Link
Scott Randal WExecutive Chairman2010-02-11Sell20,0001,830,646$17.23344.656.82Link
Cole G BradleyCOO & CFO2010-02-11Sell2,5001,000$17.5143.7854.31Link
14159 capital (GP), LLCDirector, 10% Owner2010-02-10Buy9,437113,044$17.01160.5258.85Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-02-10Buy341,8544,168,674$17.015814.9458.85Link
Baker JoffreChief Scientific Officer2010-02-09Sell4,629145,491$17.1479.3457.64Link
Cole G BradleyCOO & CFO2010-01-12Sell5,0001,000$17.2586.2556.64Link
Baker JoffreChief Scientific Officer2010-01-11Sell4,629150,120$17.4780.8754.67Link
Shak StevenChief Medical Officer2009-12-21Sell5,000388,278$20.12100.634.29Link
Popovits Kimberly JPresident and CEO2009-12-15Sell5,000313,506$20.39101.9532.52Link
Cole G BradleyCOO & CFO2009-12-14Sell2,0001,000$20.4240.8432.32Link
Scott Randal WExecutive Chairman2009-12-11Sell12,0001,880,646$20.24242.8833.5Link
Baker JoffreChief Scientific Officer2009-12-08Sell4,629154,749$20.2693.7833.37Link
Popovits Kimberly JPresident and CEO2009-11-17Sell20,000318,506$19.21384.240.66Link
Cole G BradleyCOO & CFO2009-11-12Sell6653,000$20.0413.3334.83Link
Scott Randal WExecutive Chairman2009-11-11Sell12,0001,892,646$19.99239.8835.17Link
Baker JoffreChief Scientific Officer2009-11-10Sell4,629159,378$2092.5835.1Link
Shak StevenChief Medical Officer2009-10-20Sell5,000393,278$20.65103.2530.85Link
Popovits Kimberly JPresident and CEO2009-10-15Sell5,000338,506$20.42102.132.32Link
Scott Randal WExecutive Chairman2009-10-13Sell12,0001,904,646$20.66247.9230.78Link
Baker JoffreChief Scientific Officer2009-10-07Sell4,629164,007$21.179827.63Link
Shak StevenChief Medical Officer2009-09-22Sell5,000398,278$21.13105.6527.88Link
Popovits Kimberly JPresident and CEO2009-09-15Sell5,000343,506$20.73103.6530.34Link
Scott Randal WExecutive Chairman2009-09-11Sell12,0001,916,646$20.67248.0430.72Link
Baker JoffreChief Scientific Officer2009-09-04Sell4,629168,636$20.1293.1434.29Link
Shak StevenChief Medical Officer2009-08-25Sell5,000403,278$20.77103.8530.09Link
14159 capital (GP), LLCDirector, 10% Owner2009-08-17Buy1,839103,607$19.9836.7435.24Link
Baker Brothers Life Sciences CDirector, 10% Owner2009-08-17Buy66,6303,826,820$19.981331.2735.24Link
Baker Bros. Capital (GP), LLCDirector, 10% Owner2009-08-17Buy34194,184$19.980.6835.24Link
Baker Biotech Capital (GP), LLDirector, 10% Owner2009-08-17Buy11,6571,253,653$19.98232.9135.24Link
Popovits Kimberly JPresident and CEO2009-08-17Sell5,000348,506$19.5397.6538.35Link
Cole G BradleyCOO & CFO2009-08-13Sell5,0003,000$2010035.1Link
Baker Biotech Capital (GP), LLDirector, 10% Owner2009-08-12Buy15,8771,241,996$19.49309.4438.64Link
Baker Bros. Capital (GP), LLCDirector, 10% Owner2009-08-12Buy45194,150$19.50.8838.56Link
Baker Brothers Life Sciences CDirector, 10% Owner2009-08-12Buy90,7543,760,190$19.491768.838.64Link
14159 capital (GP), LLCDirector, 10% Owner2009-08-12Buy2,508101,768$19.4948.8838.64Link
Scott Randal WExecutive Chairman2009-08-11Sell12,0001,928,646$19.42233.0439.13Link
Baker JoffreChief Scientific Officer2009-08-10Sell4,629173,265$19.4890.1738.71Link
Baker JoffreChief Scientific Officer2009-07-08Sell4,629177,894$16.0174.1168.77
Baker JoffreChief Scientific Officer2009-07-08Sell4,629177,894$16.0174.1168.77
Scott Randal WExecutive Chairman2009-06-11Sell6,0001,940,646$18.27109.6247.89
Baker JoffreChief Scientific Officer2009-06-08Sell4,629182,523$17.6981.8952.74
Shak StevenChief Medical Officer2009-05-26Sell5,000408,278$199542.21
14159 capital (GP), LLCDirector, 10% Owner2009-05-21Buy1,10899,260$17.9719.9150.36
Baker / Tisch Capital (GP), LLDirector, 10% Owner2009-05-21Buy90194,161$17.971.6250.36
Baker Brothers Life Sciences CDirector, 10% Owner2009-05-21Buy39,7783,669,436$17.97714.8150.36
Baker Bros. Capital (GP), LLCDirector, 10% Owner2009-05-21Buy25194,105$17.970.4550.36
Popovits Kimberly JPresident and CEO2009-05-15Sell5,000353,506$20.12100.634.29
Scott Randal WExecutive Chairman2009-05-12Sell12,0001,946,646$19.46233.5238.85
Baker Bros. Capital (GP), LLCDirector, 10% Owner2009-05-11Buy88194,080$19.551.7238.21
Baker / Tisch Capital (GP), LLDirector, 10% Owner2009-05-11Buy312194,071$19.556.138.21
Baker Brothers Life Sciences CDirector, 10% Owner2009-05-11Buy137,4663,629,658$19.552687.4638.21
14159 capital (GP), LLCDirector, 10% Owner2009-05-11Buy3,82798,152$19.5574.8238.21
Baker JoffreChief Scientific Officer2009-05-08Sell4,629187,152$19.7291.2837.02
Scott Randal WExecutive Chairman2009-04-14Sell12,0001,958,646$25.47305.646.09
Baker JoffreChief Scientific Officer2009-04-01Sell4,629191,781$25.27116.976.93
Scott Randal WExecutive Chairman2009-03-11Sell12,0001,970,646$19.4232.839.28
Baker JoffreChief Scientific Officer2009-03-03Sell4,629196,410$19.1388.5541.24
Cole G BradleyCOO & CFO2009-02-17Sell5,0003,000$21.52107.625.56
Baker JoffreChief Scientific Officer2009-02-12Sell4,62922,226$20.695.3631.17
Baker JoffreChief Scientific Officer2009-02-12Sell4,629201,039$20.695.3631.17
Scott Randal WExecutive Chairman, Director2009-02-11Sell12,0001,982,646$20.85250.229.59
Baker JoffreChief Scientific Officer2009-01-12Sell4,62926,855$19.4189.8539.21
Shak StevenChief Medical Officer2008-12-22Sell100413,278$20.172.0233.96
Baker JoffreChief Scientific Officer2008-12-10Sell4,62931,484$19.2589.1140.36
Baker JoffreChief Scientific Officer2008-12-10Sell4,629205,668$19.2589.1140.36
Scott Randal WCEO, Director2008-12-09Sell12,0001,955,298$18.4220.846.85
Baker JoffreChief Scientific Officer2008-11-12Sell4,62936,113$19.8791.9835.98
Baker JoffreChief Scientific Officer2008-11-12Sell4,629210,297$19.8791.9835.98
Scott Randal WCEO, Director2008-11-11Sell12,0001,967,298$20.05240.634.76
Cole G BradleyEVP & CFO2008-11-10Sell10,0004,000$20.17201.733.96
Scott Randal WCEO, Director2008-10-14Sell12,0001,979,298$20.36244.3232.71
Baker JoffreChief Scientific Officer2008-10-01Sell9,25840,742$22.51208.420.04
Shak StevenChief Medical Officer2008-09-24Sell5,000413,378$22.67113.3519.19
Scott Randal WCEO, Director2008-09-16Sell12,0001,991,298$21.79261.4824
Shak StevenChief Medical Officer2008-08-26Sell5,000418,378$22.93114.6517.84
Baker JoffreChief Scientific Officer2008-08-26Sell4,629214,926$22.69105.0319.08
Cole G BradleyEVP & CFO2008-08-18Sell9,2984,000$23.67220.0814.15
Popovits Kimberly JPresident and COO2008-08-15Sell25,000358,506$24.2460611.47
Scott Randal WCEO, Director2008-08-12Sell12,0002,003,298$23.76285.1213.72
Scott Randal WCEO, Director2008-07-15Sell12,0002,015,298$2125228.67
Baker JoffreChief Scientific Officer2008-07-01Sell4,629219,555$19.2689.1540.29
Shak StevenChief Medical Officer2008-06-24Sell100423,378$20235.1
Scott Randal WCEO, Director2008-06-10Sell12,0002,027,298$19.92239.0435.64
Baker Brothers Life Sciences CDirector, 10% Owner2008-06-09Buy320,9833,492,192$19.916390.7735.71
Baker Biotech Capital (GP), LLDirector, 10% Owner2008-06-09Buy76,0151,226,119$19.911513.4635.71
14159 capital (GP), LLCDirector, 10% Owner2008-06-09Buy10,29994,325$19.91205.0535.71
Baker JoffreChief Scientific Officer2008-06-02Sell4,629228,813$17.9983.2850.19
Scott Randal WCEO, Director2008-05-13Sell12,0002,039,298$18.7522544.11
Baker JoffreChief Scientific Officer2008-05-08Sell4,629233,442$19.2789.240.22
Scott Randal WCEO, Director2008-04-15Sell12,0002,051,298$17.22206.6456.91
Scott Randal WCEO, Director2008-03-11Sell12,0002,063,298$18.84226.0843.42
Baker JoffreChief Scientific Officer2008-03-05Sell4,629242,700$20.4894.831.93
Shak StevenChief Medical Officer2008-02-26Sell5,000423,478$20.23101.1533.56
Cole G BradleyEVP & CFO2008-02-19Sell9,0008,298$22.58203.2219.66
Scott Randal WCEO, Director2008-02-12Sell12,0002,075,298$23.01276.1217.43
Baker JoffreChief Scientific Officer2008-02-11Sell4,629247,329$22.94106.1917.79
Scott Randal WCEO, Director2008-01-15Sell12,0002,087,298$25.54306.485.79
Baker JoffreChief Scientific Officer2008-01-02Sell4,629251,958$22.66104.8919.24
Baker JoffreChief Scientific Officer2007-12-03Sell4,6290$23.1106.9316.97
Popovits Kimberly JPresident and COO2007-11-27Sell6,655383,506$22146.4122.82
Scott Randal WCEO, Director2007-11-09Sell12,0002,111,299$23.07276.8417.12
Baker JoffreChief Scientific Officer2007-11-08Sell4,629265,845$23.21107.4416.42
Scott Randal WCEO2007-10-09Sell12,0002,123,299$20.16241.9234.03
Baker JoffreChief Scientific Officer2007-10-01Sell4,629270,474$19.8491.8436.19
Scott Randal WCEO2007-09-11Sell12,0002,135,299$19.69236.2837.23
Scott Randal WCEO, Director2007-09-11Sell12,0002,135,299$19.7236.437.16
Baker JoffreChief Scientific Officer2007-09-10Sell4,629275,103$19.5790.5938.07
Goldberg Michael DDirector2007-08-23Buy5,3505,350$18.76100.3744.03
Scott Randal WCEO2007-08-15Sell12,0002,147,299$19.91238.9235.71
Baker JoffreChief Scientific Officer2007-08-08Sell4,629279,732$19.4489.9938.99
Scott Randal WCEO2007-07-18Sell12,0002,159,299$21.18254.1627.57
Baker JoffreChief Scientific Officer2007-07-02Sell4,629284,361$19.018842.14
Scott Randal WCEO2007-06-19Sell12,0002,171,299$19.16229.9241.02
Baker JoffreChief Scientific Officer2007-06-01Sell4,629288,990$17.5681.2953.87
Baker Bros. Capital (GP), LLCDirector2007-05-30Buy545193,992$16.328.8965.56
Baker Biotech Capital (GP), LLDirector2007-05-30Buy81,1811,150,104$16.321324.8765.56
Baker Brothers Life Sciences CDirector2007-05-30Buy214,0993,171,209$16.323494.165.56
14159 capital (GP), LLCDirector2007-05-30Buy6,80784,026$16.32111.0965.56
14159 capital (GP), LLCDirector2007-05-24Buy16,26177,219$16.59269.7762.87
Baker Brothers Life Sciences CDirector2007-05-24Buy511,5532,957,110$16.598486.6662.87
Baker Biotech Capital (GP), LLDirector2007-05-24Buy193,9661,068,923$16.593217.962.87
Baker Bros. Capital (GP), LLCDirector2007-05-24Buy1,303193,447$16.5921.6262.87
Baker Bros. Capital (GP), LLCDirector2007-05-21Buy1,803192,144$15.527.9574.32
14159 capital (GP), LLCDirector2007-05-21Buy22,49160,958$15.5348.6174.32
14159 capital (GP), LLCDirector2007-05-21Buy160,958$15.50.0274.32
Baker Brothers Life Sciences CDirector2007-05-21Buy707,4582,445,557$15.510965.674.32
Baker Biotech Capital (GP), LLDirector2007-05-21Buy268,248874,957$15.54157.8474.32
Baker Bros. Capital (GP), LLCDirector2007-05-21Buy1,803192,144$15.527.9574.32
Scott Randal WCEO2007-05-08Sell12,0002,183,299$16.62199.4462.58
Baker JoffreChief Scientific Officer2007-05-08Sell4,629293,619$16.3175.565.67
Scott Randal WCEO2007-04-10Sell12,0002,195,299$17.27207.2456.46
Baker JoffreChief Scientific Officer2007-04-02Sell4,629298,248$17.1679.4357.46
Baker / Tisch Capital (GP), LLDirector2007-03-09Buy3,181193,759$18.2858.1547.81
Baker Bros. Capital (GP), LLCDirector2007-03-09Buy376190,341$18.286.8747.81
Baker Biotech Capital (GP), LLDirector2007-03-09Buy62,325606,709$18.281139.347.81
Baker Brothers Life Sciences CDirector2007-03-09Buy168,5601,738,099$18.283081.2847.81
14159 capital (GP), LLCDirector2007-03-09Buy5,37538,467$18.2898.2647.81
Scott Randal WCEO2007-03-06Sell12,0002,207,299$18.35220.247.25
Baker Bros. Capital (GP), LLCDirector2007-03-02Buy119189,965$18.092.1549.36
14159 capital (GP), LLCDirector2007-03-02Buy1,70733,092$18.0930.8849.36
Baker / Tisch Capital (GP), LLDirector2007-03-02Buy1,072190,578$18.119.449.28
Baker Biotech Capital (GP), LLDirector2007-03-02Buy19,795544,384$18.09358.0949.36
Baker Brothers Life Sciences CDirector2007-03-02Buy53,5331,569,539$18.09968.4149.36
Baker JoffreChief Scientific Officer2007-03-01Sell4,629302,877$18.1884.1648.62
MYERS WOODROW A JRDirector2007-02-21Buy2,00012,000$19.6339.2637.65
Baker Brothers Life Sciences CDirector2007-02-16Buy25,4121,516,006$18.54471.1445.74
Baker Biotech Capital (GP), LLDirector2007-02-16Buy9,396524,589$18.54174.245.74
Baker / Tisch Capital (GP), LLDirector2007-02-16Buy525189,506$18.549.7345.74
14159 capital (GP), LLCDirector2007-02-16Buy81131,385$18.5415.0445.74
Baker Bros. Capital (GP), LLCDirector2007-02-16Buy56189,846$18.541.0445.74
Baker Bros. Capital (GP), LLCDirector2007-02-14Buy579189,790$18.2510.5748.05
Baker / Tisch Capital (GP), LLDirector2007-02-14Buy5,346188,981$18.2597.5648.05
Baker Biotech Capital (GP), LLDirector2007-02-14Buy95,783515,193$18.251748.0448.05
14159 capital (GP), LLCDirector2007-02-14Buy8,25630,574$18.25150.6748.05
Baker Brothers Life Sciences CDirector2007-02-14Buy259,0441,490,594$18.254727.5548.05
Scott Randal WCEO2007-02-13Sell12,0002,219,299$18.12217.4449.12
Baker JoffreChief Scientific Officer2007-02-08Sell4,629307,506$18.9787.8142.44
Baker / Tisch Capital (GP), LLDirector2006-12-06Buy642183,635$21.5813.8525.21
Baker Brothers Life Sciences CDirector2006-12-06Buy34,1731,231,550$21.58737.4525.21
14159 capital (GP), LLCDirector2006-12-06Buy1,12022,318$21.5824.1725.21
Baker Biotech Capital (GP), LLDirector2006-12-06Buy12,237419,410$21.58264.0725.21
MYERS WOODROW A JRDirector2006-12-05Buy10,00010,000$21.97219.722.99
Baker / Tisch Capital (GP), LLDirector2006-12-05Buy9,096182,993$20.6187.3831.17
Baker Biotech Capital (GP), LLDirector2006-12-05Buy173,441407,173$20.63572.8831.17
14159 capital (GP), LLCDirector2006-12-05Buy15,88021,198$20.6327.1331.17
Baker Brothers Life Sciences CDirector2006-12-05Buy484,3331,197,377$20.69977.2631.17
14159 capital (GP), LLCDirector2006-09-08Buy5,3185,318$14.0574.7292.31Link
Baker Biotech Capital (GP), LLDirector2006-09-08Buy75,246233,732$14.051057.2192.31Link
Baker Brothers Life Sciences CDirector2006-09-08Buy237,236713,044$14.053333.1792.31Link
Baker Biotech Capital III (GP)10% Owner2005-10-04Buy136,316252,529$121635.79125.17Link
Baker Biotech Capital II (GP),10% Owner2005-10-04Buy38,684181,478$12464.21125.17Link

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as Conversion of derivative security or Exercise of Options are not included. Insiders are only limited to Officers and/or Directors of the company.

"Shares" change (fifth column), "Shares Owned Following This (Direct & Indirect)" transactions (sixth column), and "Trade Price ($)" (seventh column) are split adjusted. The "Share Ownership Details" (last column) displayed data is as of reported (also split adjusted).

To find out why GuruFocus thinks data on insider trade are interesting, please read:
Also See GuruFocus Insider Trade Screener:

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK